Don't miss out! We'll send a list to your inbox, once a day. Subscribe now!

Thank you!

We've just sent you an email with your subscription link. Click on it to confirm your request.

Subscription failed!

Sorry, there seems to be an error.
tech

Elon Musk's Company Has Implanted A Brain Chip In A Human

The results after implantation are showing "promising neuron spike detection".

Cover image via The New York Times Neuralink

Follow us on InstagramTikTok, and WhatsApp for the latest stories and breaking news.

Elon Musk’s company, Neuralink, achieved a milestone by successfully implanted a brain chip in a human last week

In a post of his official X account, Musk said the individual who received the chip is recuperating. Early results also indicate promising detection of neuron spikes, he added.

The brain chip is aimed at assisting patients with severe paralysis by using their neural signals to control devices.

In May 2023, Neuralink secured approval from the US Food and Drug Administration (FDA), and in September of the same year, the company initiated its inaugural human trial, enlisting participants for comprehensive research.

Neuralink's first product is named Telepathy

Telepathy helps patients with conditions such as Amyotrophic Lateral Sclerosis communicate by manipulating cursors and typing with their thoughts.

Musk added that Telepathy could help individuals communicate faster than professional typists or auctioneers.

Neuralink is a major player in the expanding field of brain-computer interfaces

Neuralink is currently in the early stages of in-human trials. Subsequently, the company will need to undergo safety testing and collect extensive data to receive approval from the FDA.

Follow SAYS Tech on Facebook, Instagram, & TikTok for the latest in tech in Malaysia and the world!

For more #tech news:

Don't miss out on Malaysia's top stories!

We'll send a list to your inbox, once a day. Subscribe now!

Thank you!

We've just sent you an email with your subscription link. Click on it to confirm your request.

Subscription failed!

Sorry, there seems to be an error.

Leave a comment